|
|
|
|
|
|
Sponsors and Collaborators: |
Group Health Centre Pfizer |
Information provided by: | Group Health Centre |
ClinicalTrials.gov Identifier: | NCT00498147 |
The primary objective of this study is to identify whether cardiovascular complication rates are lower in patients who participate in managed diabetes care, in comparison to provincial and national rates. This study will involve an electronic medical record (EMR) chart audit, augmented by a manual review of hospital and other pertinent medical records, as necessary.
Condition |
Disease Management Diabetes Complications Diabetic Vascular Complications Diabetic Neuropathies |
MedlinePlus related topics: | Diabetes Diabetes Complications Diabetic Nerve Problems |
Study Type: | Observational |
Study Design: | Natural History, Cross-Sectional, Convenience Sample, Retrospective/Prospective Study |
Official Title: | Does Managed Diabetes Care Decrease Cardiovascular Complications of Diabetes? |
Estimated Enrollment: | 1200 |
Study Start Date: | July 2007 |
Estimated Study Completion Date: | June 2008 |
The DECIDE study will identify whether cardiovascular complication rates (the composite rate of myocardial infarction (MI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG), stroke, carotid endarterectomy, peripheral revascularization, and peripheral amputation) are lower in patients who participate in managed diabetes care by ADEC in comparison to provincial and national rates. Comparison statistics will be provided by the Institute of Evaluative Sciences (ICES) Atlas 2003 and other Diabetes studies such as the 2005 DICE study. Complications such as nephropathy and retinopathy will be documented, along with hospitilization rates and all cause mortality. Clinical outcomes relevant to diabetes management such as blood pressure and lipids will also be compared.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: David Crookston, MD | 705-759-1234 | crookston_d@ghc.on.ca |
Contact: Sharon Cuddy, BSc | 705-759-1234 ext 2292 | cuddy_s@ghc.on.ca |
Canada, Ontario | |||||
Group Health Centre | Recruiting | ||||
Sault Ste. Marie, Ontario, Canada, P6A 1Y7 | |||||
Contact: Sharon Cuddy, BSc 705-759-1234 ext 2292 cuddy_s@ghc.on.ca | |||||
Contact: Elaine Blakeborough, BSc, MBA 705-759-1234 ext 2207 blakeborough_e@ghc.on.ca |
Group Health Centre |
Pfizer |
Principal Investigator: | David Crookston, MD | The Group Health Centre |
Group Health Centre website 
  |
Study ID Numbers: | DECIDE |
First Received: | July 6, 2007 |
Last Updated: | October 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00498147 |
Health Authority: | Canada: Health Canada |
|
|
|